Novel format single-domain antibodies using human VL domain as scaffold
Xingbo Yan1, Ling Chen2, Yuqing Shen3
1Department of Microbiology and Immunology, Medical School, Southeast University, Nanjing 210009, China; Getein Biotechnology Co., Ltd., Nanjing 210000, China.
None:
Single-domain antibodies (sdAbs) represent a unique class of antibody fragments with distinct advantageous characteristics: small monomeric size, excellent solubility and high thermal stability. However, most sdAbs currently available are derived from immunized animals and require humanization for therapeutic use. Notably, sdAbs feature a longer and variable-length third complementarity-determining region (CDR3)-a key structural element for antigen binding but one that increases the technical complexity of library construction. To address these challenges, this study, for the first time, describes the development of synthetic sdAb libraries using a stability-engineered human light-chain variable domain (VL) as the scaffold. We performed limited randomization on three loops located on the opposite side of the CDRs using degenerate codons, which were designed based on the natural length and amino acid properties of these loops. Eukaryotic expression assays confirmed that sdAbs generated via this randomization strategy exhibit excellent secretory expression efficiency. We constructed two ribosome display libraries using two sets of degenerate codon primers and compared the panning efficiency of two strategies against four model antigens (Jo-1, SSB, HAV, and CRP): standalone ribosome display and a combined approach of ribosome display followed by phage pIX display. Both strategies successfully yielded target-specific binders, with the combined panning method demonstrating superior performance to standalone ribosome display. The results demonstrate that synthetic sdAb libraries based on a stability-optimized human VL scaffold provide a facile and reliable source of functional sdAbs. This innovative design is anticipated to serve as a promising platform for the development of next-generation single-domain bispecific antibodies.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
